These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8187213)

  • 1. The apolipoprotein(a) gene: characterization of 5' flanking regions and expression in transgenic mice.
    Lawn RM
    Chem Phys Lipids; 1994 Jan; 67-68():19-23. PubMed ID: 8187213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
    Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
    Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
    Liu AC; Lawn RM; Verstuyft JG; Rubin EM
    J Lipid Res; 1994 Dec; 35(12):2263-7. PubMed ID: 7897323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.
    Wade DP; Clarke JG; Lindahl GE; Liu AC; Zysow BR; Meer K; Schwartz K; Lawn RM
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1369-73. PubMed ID: 7679504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP; Newland DL; Mooser V; Murata J; Marcovina S; Young SG; Hammer RE; Sanan DA; Hobbs HH
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1911-6. PubMed ID: 7583571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the apolipoprotein(a) gene.
    Ichinose A
    Biochem Biophys Res Commun; 1995 Apr; 209(1):365-71. PubMed ID: 7726858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein (a)].
    Okubo M
    Nihon Rinsho; 1994 Dec; 52(12):3133-8. PubMed ID: 7853701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis.
    Palabrica TM; Liu AC; Aronovitz MJ; Furie B; Lawn RM; Furie BC
    Nat Med; 1995 Mar; 1(3):256-9. PubMed ID: 7585043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of polymorphisms in the 5'-flanking region of the gene for apolipoprotein(a).
    Ichinose A; Kuriyama M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):372-8. PubMed ID: 7726859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B.
    Rouy D; Duverger N; Lin SD; Emmanuel F; Houdebine LM; Denefle P; Viglietta C; Gong E; Rubin EM; Hughes SD
    J Biol Chem; 1998 Jan; 273(2):1247-51. PubMed ID: 9422793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial hardening in mice.
    Scott J
    Nature; 1992 Dec; 360(6405):631-2. PubMed ID: 1465121
    [No Abstract]   [Full Text] [Related]  

  • 15. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.
    Frazer KA; Narla G; Zhang JL; Rubin EM
    Nat Genet; 1995 Apr; 9(4):424-31. PubMed ID: 7795650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
    Lou XJ; Boonmark NW; Horrigan FT; Degen JL; Lawn RM
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12591-5. PubMed ID: 9770530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic rabbits expressing human apolipoprotein(a) as a useful model for the study of lipoprotein(a).
    Fan J; Challah M; Shimoyamada H; Watanabe T
    Ann N Y Acad Sci; 2000 May; 902():347-51. PubMed ID: 10865861
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the structure and function of the apolipoprotein(a) gene.
    Byrne CD; Lawn RM
    Clin Genet; 1994 Jul; 46(1 Spec No):34-41. PubMed ID: 7988075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
    Prins J; Leus FR; Bouma BN; van Rijn HJ
    Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.